InvestorsHub Logo
Followers 29
Posts 3613
Boards Moderated 0
Alias Born 07/28/2009

Re: Duke2484 post# 87253

Tuesday, 10/25/2016 9:08:27 AM

Tuesday, October 25, 2016 9:08:27 AM

Post# of 330228
I respectfully disagree with your eval of the eventual pps. This stock actually will become, as you eluded to as a miracle, based on the reality--not hype, that the products are aiming squarely at massive multi-billion pain markets and a lot of those. This is not just a simple penny stock in that sense and with it already beginning to gain market traction on the store and pharmacy shelves in a number of major countries--it is a real product with massive upside in its acceptance by most who have tried it. That means repeat sales which will eventually help maintain sales and eventually propel sales. And this is not just another pain product--it is new technology at a disruptive price point, disruptive size and ease of use, disruptive ability in how it treats pain, disruptive in its ability to offer relief with zero side effects. That will be huge with those in need of relief. Don't underestimate. I have no doubt there are major companies waiting to purchase BIEL upon FDA approval, who are all waiting like the rest of us. Simpsonly is right in his evaluation opinion. After the dust settles and we end up between .08-.12 just wait and hold if you can. Over the long term, this will climb even further as this will likely become a household-name kind of product. My two cents.